Filter
2820
Filtered Results: 2820
Text search:
Drug
Resistance
Featured
Recommendations
300
New Publications
745
Language
Document type
No document type
1629
Studies & Reports
424
Guidelines
421
Manuals
119
Strategic & Response Plan
90
Fact sheets
54
Training Material
41
Situation Updates
15
Infographics
12
Online Courses
5
Resource Platforms
4
Brochures
3
Videos
3
Countries / Regions
India
153
South Africa
80
Kenya
79
Global
76
Western and Central Europe
74
Ethiopia
60
Uganda
51
Nepal
48
Tanzania
48
Eastern Europe
47
Africa
42
Zambia
40
Nigeria
39
Liberia
37
Sierra Leone
34
Latin America and the Carribbean
34
Malawi
32
Philippines
31
Myanmar / Burma
30
Ghana
29
Bangladesh
28
Rwanda
27
Asia
24
Namibia
24
Lesotho
22
Cambodia
22
South–East Asia Region
21
Zimbabwe
20
Indonesia
19
Ukraine
18
Russia
18
Senegal
17
Botswana
14
Congo, Democratic Republic of
13
Mozambique
12
Colombia
11
Cameroon
11
Venezuela
10
Syria
9
Thailand
8
Albania
8
Burkina Faso
8
West and Central Africa
8
Middle East and North Africa
8
Eastern Europe and Central Asia
8
Eswatini/ Swaziland
8
Germany
7
East and Southern Africa
7
Argentina
7
Pakistan
7
Tajikistan
6
USA
6
Haiti
6
Benin
5
Laos
5
Guinea
5
Vietnam
5
Georgia
5
China
4
Peru
4
Western Pacific Region
4
Brazil
4
Sudan
4
Iraq
4
North Macedonia
3
El Salvador
3
Iran
3
Estonia
3
Afghanistan
3
Jordan
3
Paraguay
3
Uruguay
3
Lebanon
3
Sri Lanka
3
Central African Republic
3
Bhutan
3
South Sudan
3
Somalia
3
Timor Leste/ East Timor
2
Mexico
2
Morocco
2
Armenia
2
Saudi Arabia
2
Gabon
2
Tunisia
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Moldova
2
Yemen
2
Mali
2
Libya
2
Ecuador
2
Madagascar
2
Switzerland
1
Serbia
1
Turkey
1
Gambia
1
Kazakhstan
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Niger
1
Qatar
1
Italy
1
Guinea-Bissau
1
North America
1
Turkmenistan
1
Jamaica
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
Bolivia
1
Nicaragua
1
Egypt
1
Romania
1
Greece
1
Honduras
1
Angola
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
995
Clinical Guidelines
310
Public Health
127
Women & Child Health
81
Key Resources
72
Capacity Building
38
Pharmacy & Technologies
37
Annual Report MEDBOX
1
Toolboxes
TB
505
HIV
343
AMR
328
NTDs
119
Mental Health
111
COVID-19
94
Pharmacy
75
Rapid Response
61
Caregiver
49
Planetary Health
48
NCDs
37
Ebola & Marburg
33
Global Health Education
32
Refugee
31
Polio
17
Conflict
14
Cholera
13
Health Financing Toolbox
13
Disability
11
Natural Hazards
8
Zika
5
Specific Hazards
3
Social Ethics
3
Malaria
1
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i...
This course will provide you with the knowledge and skills needed to implement WHO-recommended TB tests and algorithms. It includes the latest recommendations for novel tests for TB diagnosis and detection of drug resistance, as well as the most recent WHO policy guidance for the use of those tests....
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...
Every day, fake medicines and medical products are sold at street corners, in open air markets or on unregulated websites in several countries in the African Region. These poor quality, unsafe medicines and pharmaceutical products promote drug resistance and lead to loss of confidence in health prof...
This job aid provides information for laboratorians about how to receive, process, and store dried blood spot specimens collected for early infant diagnosis, viral load, or drug resistance testing.
Human African Trypanosomiasis (HAT, sleeping sickness) and Animal African Trypanosomiasis (AAT) are neglected tropical diseases generally caused by the same etiological agent, Trypanosoma brucei. Despite important advances in the reduction or disappearance of HAT cases, AAT represents a risky reserv...
Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection
recommended
The recommendations in these guidelines promote the use of simple, non-invasive diagnostic tests to assess the stage of liver disease and eligibility for treatment; prioritize treatment for those with most advanced liver disease and at greatest risk of mortality; and recommend the preferred use of n...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
It is essential that all people, including people living with HIV, are able to access health services and ongoing treatment. If people living with HIV who are on ART stop abruptly because they cannot access new supplies they could rapidly become unwell, drug resistance may build and the chances of o...
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa...
Each year, WHO’s World malaria report provides a comprehensive and up-to-date assessment of trends in malaria control and elimination across the globe. This year’s report includes, for the first time, a dedicated chapter focused on the intersection between climate change and malaria. As describe...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Ahead of World Malaria Day, the WHO Global Malaria Programme published a new operational strategy outlining its priorities and key activities up to 2030 to help change the trajectory of malaria trends, with a view to achieving the global malaria targets. The strategy outlines 4 strategic objectives ...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
The reports bring together the latest findings and conclusions about the state of resistance to artemisinins and artemisinin-based combination therapy (ACT), summarize WHO’s current policy and treatment recommendations, and highlight areas of concern.
Antimicrobial resistance (AMR) occurs when disease-causing pathogens are able to withstand the killing or suppressing power of antimicrobial medicines. This phenomenon increases the global burden of infectious diseases and strains health systems.This course aims to improve the learner's awareness an...
This training toolkit by the European Laboratory Initiative for TB, HIV and Viral Hepatitis provides a unique combination of practical guidance and expert advice on the interpretation of selected WHO-endorsed tests for drug-resistant tuberculosis (DR-TB).
